Nutanix, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell

38

NTNX
Nutanix, Inc.

Last Price:

$47.58

Seasonality Move:

-6.6%

Sell

39

NKTR
Nektar Therapeutics

Last Price:

$54.70

Seasonality Move:

11.58%

Sell

38

Nutanix, Inc. (NTNX) is a Sell

Is Nutanix, Inc. a Buy, Sell or Hold?

The current Nutanix, Inc. [NTNX] share price is $47.58. The Score for NTNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
NTNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

39

Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTNX Stock Price Chart

What is Nutanix, Inc.'s stock price today?

The Nutanix, Inc. share price today is $47.58

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTNX is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

The Nektar Therapeutics share price today is $54.70

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

NTNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-5.17	Sell
Relative Strength Index (14 RSI):	23.32	Sell
Chaikin Money Flow:	-2724204	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(47.11 - 65.07)	Sell
Bollinger Bands (100):	(59.13 - 76.77)	Sell

NKTR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.71	Sell
Relative Strength Index (14 RSI):	45.77	Sell
Chaikin Money Flow:	141668	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(54.71 - 61.07)	Sell
Bollinger Bands (100):	(32.74 - 62.56)	Buy

NTNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	47.42	Buy
20-day SMA:	52.87	Sell
50-day SMA:	62.86	Sell
200-day SMA:	70.18	Sell
8-day EMA:	48.12	Sell
20-day EMA:	52.57	Sell
50-day EMA:	60.19	Sell
200-day EMA:	67.16	Sell

NKTR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	56.42	Sell
20-day SMA:	58.12	Sell
50-day SMA:	58.41	Sell
200-day SMA:	30.65	Buy
8-day EMA:	56.16	Sell
20-day EMA:	57.43	Sell
50-day EMA:	55.78	Sell
200-day EMA:	37.86	Buy

Nutanix, Inc. Earnings Growth & NTNX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.09 per share, an increase this year of $0.52 per share, and an increase next year of $0.06 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Nutanix, Inc. Technical Analysis

	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12
	Dec
	01	02	03	04	05	08	09	10	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12
	Dec
	01	02	03	04	05	08	09	10	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):